US 9074213
Compositions and methods for inhibiting expression of a target gene
granted A61KA61K38/00A61P
Quick answer
US patent 9074213 (Compositions and methods for inhibiting expression of a target gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61P, A61P25/28, A61P31/12